4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001415889-24-019814
EVP, R&D AND CSO sold 41,783 shares at an average $6.93 ($289,492)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morisset Valerie EVP, R&D AND CSO | 2024-07-17 | Sale | −3,207 | $6.91 | $22,160 | 199,099 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-18 | Sale | −38,576 | $6.93 | $267,332 | 160,523 | D |
| Open-market sales · 41,783 sh · avg $6.93 · $289,492 | |||||||
Loading xslF345X05/form4-07192024_030734.xml…